BMY

4 Pharmaceutical Stocks to Buy Now

Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More 

Should I Buy Merck? 3 Pros, 3 Cons

Merck is in the midst of a prolonged downtrend after hitting multiyear highs in 2012. Should you get in, or keep avoiding the Big Pharma stock? More 

3 Pharmaceutical Stocks to Buy Now

Three Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More 

Sector Scan: Pharmaceutical Stocks

In the pharmaceutical sector, my scans have revealed four names to buy on strength and one stinker to avoid at all costs or sell if you own it. More 

Big Businesss Come Together to Support Gay Marriage

A number of companies including Aetna, eBay, Marriott, Bristol-Myers Squibb and Thomson Reuters, have formed a coalition to advance gay marriage. More 

Zoetis: The Biggest IPO Since Facebook

Pfizer's animal health division, Zoetis, could raise more than $2 billion, making it the largest IPO since Facebook. Here's a look at the Zoetis deal, as well as three others on tap for this week. More 

Apple Just Can’t Please — Wednesday’s IP Market Recap

Apple stock was being hit hard in postmarket trading Wednesday despite a record earnings report. However, Netflix was setting off fireworks. More